Compound blends during transition periods Some compounding pharmacies offer GLP-1 formulations blended with additional compounds like B12 , glycine , L-carnitine , or niacinamide
Recommended clinical approach includes: Baseline evaluation : Consider obtaining serum creatinine, eGFR, and urinalysis before initiating either substance
,
They do not involve GLOW Blend, NovaGlo Research products, or any material sold by NovaGlo
This approach aligns well with the nature of autoimmune conditions where the fundamental problem is regulatory failure
The results were significant: At 48 weeks, participants receiving the 12 mg dose achieved a mean weight reduction of 24.2% (approximately 58 pounds or 26.2 kg) 100% of participants on the 8 mg or 12 mg doses lost at least 5% of their body weight More than 90% of participants on the 12 mg dose lost at least 10% of their body weight Nearly half of participants on the highest dose lost 25% or more of their body weight The study also showed improvements in cardiometabolic markers including blood pressure, triglycerides, LDL cholesterol, and fasting glucose